Skip to main content

Table 2 Demographic data and baseline information

From: A prospective, multi-centre, observational study to examine kidney disease progression in adults with chronic kidney disease – CKDOD - Study design and preliminary results

 

Total

India

Thailand

Malaysia

China

Number of patients enrolled, N

1323

1137

56

80

50

Males, %

881 (67 %)

759 (67 %)

36 (64 %)

53 (66 %)

33 (66 %)

Age, mean (SD)

57 (±14)

56 (±14)

67 (±12)

68 (±10)

50 (±15)

BMI, mean (SD)

25.2 (±4.8)

25.2 (±4.8)

24.1 (±4.8)

26.8 (±5.7)

24.6 (±3.4)

First blood pressure in mmHg, mean (SD)

135/81 (±15/10)

134/83 (±15/9)

133/68 (±17/11)

139/74 (±15/13)

132/82 (±13/11)

First creatinine in mg/dL, mean (SD)

3.2 (±1.9)

3.4 (±2.0)

2.6 (±1.2)

2.4 (±0.6)

2.1 (±1.3)

First eGFR in ml/min/1.73 m2 (EPI), mean (SD)

26.0 (±16.4

25.0 (±16.2)

26.8 (±12.2)

26.8 (±8.4)

44.8 (±23.0)

Patients on low or very low protein diet with ketoanalogue supplementation at any visit, %

324 (24 %)

284 (25 %)

2 (4 %)

20 (25 %)

18 (36 %)

Patients on low or very low protein diet without ketoanalogue supplementation at any visit, %

249 (19 %)

178 (16 %)

4 (7 %)

37 (46 %)

30 (60 %)